Article 1
To ensure national economic security, protect public interests, and regulate the management of state secrets and archives related to overseas issuance and listing by Zhejiang Jingxin Pharmaceutical Co., Ltd. and all domestic enterprises within its consolidated financial statements (hereinafter referred to as "the Company"), this system is formulated in accordance with the "Securities Law of the People's Republic of China," "Law of the People's Republic of China on Guarding State Secrets," "Archives Law of the People's Republic of China," "Trial Measures for Management of Overseas Securities Issuance and Listing by Domestic Enterprises," and "Regulations on Strengthening Confidentiality and Archive Management Related to Overseas Securities Issuance and Listing by Domestic Enterprises."
Article 2
The term "overseas issuance and listing" as used in this system refers to the Company's direct or indirect issuance of securities and/or listing outside the People's Republic of China. This system applies to the entire process of the Company's overseas issuance and listing.
Article 3
This system applies to Zhejiang Jingxin Pharmaceutical Co., Ltd. and all domestic enterprises within its consolidated financial statements, including the Company's subsidiaries and branches.
Article 4
State secrets are matters related to national security and interests, determined by legal procedures, and known only to a limited number of personnel for a certain period. Business and technical information that falls within the scope of state secrets must be protected in accordance with relevant state secret regulations.
Article 5
If documents containing state secrets or secrets of state organs are generated during the Company's overseas issuance and listing process, confidentiality measures must be taken in advance, and the relevant business department or confidentiality administrative management department with appropriate classification authority must be notified immediately.